A Robust Portfolio of Cancer Clinical Trials
The Froedtert & MCW Cancer Network offers Wisconsin's largest portfolio of cancer clinical trials, with more than 200 active studies.
Adult Clinical Trials
View all active adult clinical trials available through the Froedtert & the Medical College of Wisconsin Cancer Network.
Pediatric Clinical Trials
Browse pediatric cancer clinical trials conducted through Children's Wisconsin and the MACC Fund Center for Cancer and Blood Disorders.
Physician Referrals
Visit MCW Physician ACCESS (All Cancer Enrolling Studies) to locate a potential match for adult and pediatric patients.
National Leadership in Clinical Trials
As one of a select group of Lead Academic Participating Sites (LAPS) in the National Clinical Trials Network, our investigators help lead the studies that establish new standards of cancer care. This distinction recognizes exceptional scientific leadership, clinical research expertise and the ability to bring groundbreaking clinical trials to patients.
Translational Research Units
The Froedtert & MCW Cancer Network is one of only a few cancer care networks in the nation with two dedicated cancer translational research units, including Wisconsin’s only inpatient unit. Designed specifically for early-phase clinical research, these specialized units provide investigators with the facilities, technology, and experienced teams needed to evaluate emerging therapies.
Clinical Research Support
The MCW Cancer Center supports investigators throughout the clinical research process, with resources for protocol development, regulatory guidance, study activation, trial management, and scientific review.
- Disease-Oriented Teams
- Clinical Trials Office
- Institutional Review Board
- Scientific Review Committee
- Translational Council
Innovative Neuroimaging Technique Could Improve Outcomes for Patients with Glioblastoma
An innovative approach known as radiopathomic mapping combines advanced imaging technology with artificial intelligence to provide a more accurate and comprehensive understanding of how tumors evolve over time, leading to better, more targeted treatments for patients.
MCW Cancer Center Launches MyeloMATCH to Advance Precision Medicine for Myeloid Cancers
The MCW Cancer Center’s Clinical Trials Office recently activated the phase 2 MyeloMATCH screening study, that tests patients’ blood and bone marrow for biomarkers to guide treatment decisions and match them to personalized clinical trials.
PROTECT-PANC Trial Evaluates Precision Medicine Strategies in Patients with Pancreatic Cancer
The fast-track trial bolsters MCW’s dedication to advancing precision medicine strategies across a spectrum of cancer types.